Eric Crampton, Chief Economist at the New Zealand Initiative joins us once again. Tonight he's asking if the idea to void vaccine patents will improve worldwide access to a covid vaccine in reality, or are the bottlenecks elsewhere in the system?
The production line inside the pharmaceutical plant Fareva. Photo: AFP or licensors
